This activity was planned with a goal to enable participants to understand atrial fibrillation care based on recent guidelines, with a focus on the role of antiarrhythmic drugs in early onset of atrial fibrillation. This activity is part of the Early Onset of Atrial Fibrillation & the Contemporary Use of Antiarrhythmic Drugs grant project supported by Sanofi. 

Important Dates: 
Date of Release: October 28, 2024
Term of Approval/Date of Expiration: October 31, 2025
 
Learner Objectives:  
Upon completion of this activity, you should be able to: 

• Contrast research by interpreting recent clinical trial data on rhythm control strategies and implications for patient care.   

Acknowledgement 
Educational grant support provided by: Sanofi.

Faculty:
Paulus Kirchhof, MD, FESC  

Peer Reviewer:
Suneet Mittal, MD, FACC, FHRS